Category: Include on Menu

  • SciSparc’s NeuroThera Labs reports publication of international patent application

    SciSparc’s NeuroThera Labs reports publication of international patent application

    SciSparc (NASDAQ: SPRC) announced that NeuroThera Labs, a subsidiary in which it holds an approximately 75% controlling stake, has progressed its collaboration with Clearmind Medicine (NASDAQ:CMND) following the publication of an international patent application under the Patent Cooperation Treaty. The patent relates to a new combination therapy designed to target weight loss and metabolic dysfunction-associated…

  • Eightco secures $125M in funding, invests in OpenAI and Beast Industries

    Eightco secures $125M in funding, invests in OpenAI and Beast Industries

    Eightco Holdings Inc. (NASDAQ:ORBS) announced it has secured $125 million in funding commitments and completed $75 million in strategic investments in OpenAI and Beast Industries, according to a company press release. Bitmine (NYSE:BMNR) contributed $75 million to the financing round, while ARK Invest and Payward—the parent company of the cryptocurrency exchange Kraken—each committed $25 million.…

  • Robin Energy raises $13.9M via ATM program in early 2026

    Robin Energy raises $13.9M via ATM program in early 2026

    Robin Energy Ltd. (NASDAQ:RBNE) said Wednesday it has generated $13.9 million in gross proceeds through its at-the-market (ATM) share issuance program since the start of the first quarter of 2026. The international shipping company sold shares at an average price of $4.31 each, representing a 138% premium to Wednesday’s closing price of $1.81. Despite that…

  • Incannex outlines dose-optimization study for sleep apnea treatment

    Incannex outlines dose-optimization study for sleep apnea treatment

    Incannex Healthcare Inc. (NASDAQ:IXHL) on Thursday detailed an updated clinical development plan for IHL-42X, its oral treatment candidate for obstructive sleep apnea, following results from its Phase 2 trial. The company said it intends to launch a Phase 2 crossover dose-optimization study known as DReAMzz, which will assess various ratios of the drug’s two active…

  • Dollar General shares fall after sales outlook disappoints despite strong rally

    Dollar General shares fall after sales outlook disappoints despite strong rally

    Dollar General (NYSE:DG) shares fell more than 5% in premarket trading on Thursday after the discount retailer issued annual comparable sales guidance that failed to meet elevated expectations on Wall Street following a sharp run-up in the stock. Recent economic data suggest that growth in the U.S. economy has been increasingly driven by higher-income households…

  • America’s Car-Mart reports wider quarterly loss as revenue misses forecasts

    America’s Car-Mart reports wider quarterly loss as revenue misses forecasts

    America’s Car-Mart Inc. (NASDAQ:CRMT) on Thursday reported a third-quarter loss that was larger than analysts had anticipated, as the used-car retailer posted revenue below expectations amid capital constraints and disruptions caused by severe winter weather. Despite the results, the company’s shares rose 1.99% in premarket trading. For the quarter ended January 31, 2026, the company…

  • G-III Apparel shares drop nearly 13% after earnings miss and weak outlook

    G-III Apparel shares drop nearly 13% after earnings miss and weak outlook

    G-III Apparel Group, Ltd. (NASDAQ:GIII) reported fourth-quarter results on Thursday that fell short of analyst expectations and issued a weaker-than-expected outlook for fiscal 2027 as the company exits its licensing agreements with Calvin Klein and Tommy Hilfiger. The company’s shares declined 12.75% in premarket trading following the announcement. For the fourth quarter ended January 31,…

  • Village Farms shares tumble nearly 12% after fourth-quarter earnings miss

    Village Farms shares tumble nearly 12% after fourth-quarter earnings miss

    Village Farms International, Inc. (NASDAQ:VFF) reported fourth-quarter results on Thursday that fell short of analyst expectations. Following the release, the company’s shares dropped 11.97% in premarket trading. The cannabis and produce company reported adjusted earnings per share of $0.01 for the quarter, below the analyst consensus estimate of $0.02. Revenue totaled $49.6 million, well under…

  • Lifetime Brands shares surge nearly 27% after strong fourth-quarter earnings beat

    Lifetime Brands shares surge nearly 27% after strong fourth-quarter earnings beat

    Lifetime Brands, Inc. (NASDAQ:LCUT) reported fourth-quarter adjusted earnings per share of $1.05 on Thursday, far surpassing the analyst consensus estimate of $0.32, although revenue came in below expectations. The company’s shares jumped 26.82% in premarket trading following the results, as investors reacted positively to the strong profit performance. Revenue for the quarter ended December 31,…

  • KLA shares rise after $7B buyback announcement and dividend increase

    KLA shares rise after $7B buyback announcement and dividend increase

    KLA Corporation (NASDAQ:KLAC) gained 1.3% on Thursday, outperforming the broader technology sector as the Nasdaq 100 slipped 0.4%, after the semiconductor equipment manufacturer unveiled a $7 billion share repurchase program and increased its dividend by 21%. The new buyback authorization adds to an existing program that still had $3.944 billion available as of December 31,…